Funding
Series A · Healthtech

Latent raises $80m Series A for medication-access technology

Spark Capital, Transformation Capital and other investors participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Latent raised $80 million in Series A financing on April 7. Participants included Spark Capital, Transformation Capital, Conviction, McKesson Ventures, General Catalyst and Y Combinator. The company develops a clinical-reasoning system for medication-access workflows.

Funding history

Series A · This round$80M

Sources

  1. Latentprojectstartups.com
  2. businesswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related